134 related articles for article (PubMed ID: 24530395)
1. Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors.
Jäntti MH; Mandrika I; Kukkonen JP
Biochem Biophys Res Commun; 2014 Mar; 445(2):486-90. PubMed ID: 24530395
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of the human cannabinoid receptor coding region splice variants (hCB₁) affects the function of hCB₁ receptor complexes.
Bagher AM; Laprairie RB; Kelly ME; Denovan-Wright EM
Eur J Pharmacol; 2013 Dec; 721(1-3):341-54. PubMed ID: 24091169
[TBL] [Abstract][Full Text] [Related]
3. OX2 orexin/hypocretin receptor signal transduction in recombinant Chinese hamster ovary cells.
Kukkonen JP
Cell Signal; 2016 Feb; 28(2):51-60. PubMed ID: 26582739
[TBL] [Abstract][Full Text] [Related]
4. Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray.
Lee HJ; Chang LY; Ho YC; Teng SF; Hwang LL; Mackie K; Chiou LC
Neuropharmacology; 2016 Jun; 105():577-586. PubMed ID: 26907809
[TBL] [Abstract][Full Text] [Related]
5. Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling.
Jäntti MH; Putula J; Turunen PM; Näsman J; Reijonen S; Lindqvist C; Kukkonen JP
Mol Pharmacol; 2013 Mar; 83(3):621-32. PubMed ID: 23233488
[TBL] [Abstract][Full Text] [Related]
6. Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences.
Ramsay D; Kellett E; McVey M; Rees S; Milligan G
Biochem J; 2002 Jul; 365(Pt 2):429-40. PubMed ID: 11971762
[TBL] [Abstract][Full Text] [Related]
7. Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function.
Ellis J; Pediani JD; Canals M; Milasta S; Milligan G
J Biol Chem; 2006 Dec; 281(50):38812-24. PubMed ID: 17015451
[TBL] [Abstract][Full Text] [Related]
8. Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors.
Harikumar KG; Morfis MM; Lisenbee CS; Sexton PM; Miller LJ
Mol Pharmacol; 2006 Jan; 69(1):363-73. PubMed ID: 16244179
[TBL] [Abstract][Full Text] [Related]
9. Changes and overlapping distribution in the expression of CB1/OX1-GPCRs in rat hippocampus by kainic acid-induced status epilepticus.
Zhu F; Wang XQ; Chen YN; Yang N; Lang SY; Zuo PP; Zhang JT; Li RS
Brain Res; 2015 Feb; 1597():14-27. PubMed ID: 25446454
[TBL] [Abstract][Full Text] [Related]
10. OX1 orexin/hypocretin receptor signaling through arachidonic acid and endocannabinoid release.
Turunen PM; Jäntti MH; Kukkonen JP
Mol Pharmacol; 2012 Aug; 82(2):156-67. PubMed ID: 22550093
[TBL] [Abstract][Full Text] [Related]
11. The role of diacylglycerol lipase in constitutive and angiotensin AT1 receptor-stimulated cannabinoid CB1 receptor activity.
Turu G; Simon A; Gyombolai P; Szidonya L; Bagdy G; Lenkei Z; Hunyady L
J Biol Chem; 2007 Mar; 282(11):7753-7. PubMed ID: 17227758
[TBL] [Abstract][Full Text] [Related]
12. Orexin Receptor Multimerization versus Functional Interactions: Neuropharmacological Implications for Opioid and Cannabinoid Signalling and Pharmacogenetics.
Thompson MD; Sakurai T; Rainero I; Maj MC; Kukkonen JP
Pharmaceuticals (Basel); 2017 Oct; 10(4):. PubMed ID: 28991183
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptors.
Govaerts SJ; Muccioli GG; Hermans E; Lambert DM
Eur J Pharmacol; 2004 Jul; 495(1):43-53. PubMed ID: 15219819
[TBL] [Abstract][Full Text] [Related]
14. Bidirectional allosteric interactions between cannabinoid receptor 1 (CB
Bagher AM; Laprairie RB; Toguri JT; Kelly MEM; Denovan-Wright EM
Eur J Pharmacol; 2017 Oct; 813():66-83. PubMed ID: 28734930
[TBL] [Abstract][Full Text] [Related]
15. Formation of OX-1R/CB1R heteromeric complexes in embryonic mouse hypothalamic cells: Effect on intracellular calcium, 2-arachidonoyl-glycerol biosynthesis and ERK phosphorylation.
Imperatore R; Palomba L; Morello G; Spiezio AD; Piscitelli F; Marzo VD; Cristino L
Pharmacol Res; 2016 Sep; 111():600-609. PubMed ID: 27436148
[TBL] [Abstract][Full Text] [Related]
16. Toward the Development of Bivalent Ligand Probes of Cannabinoid CB1 and Orexin OX1 Receptor Heterodimers.
Perrey DA; Gilmour BP; Thomas BF; Zhang Y
ACS Med Chem Lett; 2014 Jun; 5(6):634-8. PubMed ID: 24944734
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis.
Terrillon S; Durroux T; Mouillac B; Breit A; Ayoub MA; Taulan M; Jockers R; Barberis C; Bouvier M
Mol Endocrinol; 2003 Apr; 17(4):677-91. PubMed ID: 12554793
[TBL] [Abstract][Full Text] [Related]
18. Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity.
Turku A; Rinne MK; Boije Af Gennäs G; Xhaard H; Lindholm D; Kukkonen JP
PLoS One; 2017; 12(6):e0178526. PubMed ID: 28575023
[TBL] [Abstract][Full Text] [Related]
19. Selective orexin receptor antagonists.
Lebold TP; Bonaventure P; Shireman BT
Bioorg Med Chem Lett; 2013 Sep; 23(17):4761-9. PubMed ID: 23891187
[TBL] [Abstract][Full Text] [Related]
20. Distinct recognition of OX1 and OX2 receptors by orexin peptides.
Ammoun S; Holmqvist T; Shariatmadari R; Oonk HB; Detheux M; Parmentier M; Akerman KE; Kukkonen JP
J Pharmacol Exp Ther; 2003 May; 305(2):507-14. PubMed ID: 12606634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
